DCF — ST. VINCENTS MEDICAL CENTER
Enterprise Value: $-943.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-943.8M
Enterprise Value
$-295.4M
PV of Cash Flows
$-648.4M
PV of Terminal Value
$-1.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $495.8M | $-60.5M | -12.0% | $-81.5M | $-74.1M |
| Year 2 | $510.7M | $-57.2M | -11.0% | $-78.9M | $-65.2M |
| Year 3 | $526.0M | $-53.7M | -10.0% | $-76.0M | $-57.1M |
| Year 4 | $541.8M | $-52.6M | -10.0% | $-75.5M | $-51.6M |
| Year 5 | $558.0M | $-52.8M | -9.0% | $-76.4M | $-47.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-943.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$481.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1271010467700337
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5